C0820 CLINDAMYCIN P04 1% TOP SWAB 36C77025Q0278
ID: 36C77025Q0278Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

No Set aside used (NONE)

Original Source

https://sam.gov/opp/ccbce93c089e439db9dcaec7d16a9733/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Clindamycin P04 1% topical swabs, specifically intended for various Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. Vendors are required to submit their quotes via email by August 7, 2025, ensuring that the products meet specifications, including a minimum shelf life of one year upon delivery and compliance with pharmaceutical labeling standards. This procurement is crucial for maintaining an efficient supply chain of essential pharmaceuticals for veteran healthcare services. Interested vendors can contact Kayla Powers at kayla.powers@va.gov or by phone at 913-758-9915 for further details.

    Point(s) of Contact
    Kayla Powers
    (913) 758-9915
    kayla.powers@va.gov
    Files
    Title
    Posted
    S02.36C77025Q0278.docx
    The file outlines a government Request for Proposal (RFP) managed by the Department of Veterans Affairs, specifically focusing on the procurement of Clindamycin 1% topical swabs for various Consolidated Mail Outpatient Pharmacy (CMOP) locations. It indicates that the RFP is soliciting bids from eligible contractors with specific requirements for submission, including pricing schedules and requisite certifications. The document emphasizes compliance with several Federal Acquisition Regulations and provides detailed instructions regarding delivery, invoicing, and performance evaluations. To facilitate vendor participation, emphasis is placed on the need for clear documentation of product availability, shipping conditions, and adherence to pharmaceutical labeling standards, including barcoding practices and adherence to the Drug Supply Chain Security Act. The pricing schedule highlights various quantities and delivery requirements across multiple delivery points, ensuring that contractors understand the staggered delivery expectations. Overall, the RFP aims to streamline procurement processes, maintain regulatory compliance, and ensure quality and reliability in pharmaceutical supplies for veteran healthcare services.
    S02.Pricing Schedule_.xlsx
    The document outlines a Request for Proposal (RFP) from the federal government for the procurement of CLINDAMYCIN PO4 1% TOP SWAB in multiple quantities, primarily intended for the Chelmsford, Tucson, Dallas-Lancaster, Murfreesboro-EF, Hines, and Charleston Community-Based Outpatient Pharmacies (CMOP). Vendors are required to submit their quotes via email by August 7, 2025, and ensure that products meet the specification of having a minimum shelf life of one year upon delivery. Key submission requirements include a completed solicitation cover page (SF1449), a quote spreadsheet, and proof of a valid wholesale distributor license. Detail is needed in vendor comments regarding any deviations in National Drug Codes (NDC) or expiration dates. The document emphasizes the importance of adhering to delivery timelines, with an initial delivery expected within ten days after receipt of the order (ARO). This procurement activity aims to ensure the timely availability of essential pharmaceuticals for veteran healthcare services, reflecting the government's commitment to maintaining efficient supply chains for medical supplies.
    Lifecycle
    Title
    Type
    C0820 CLINDAMYCIN P04 1% TOP SWAB 36C77025Q0278
    Currently viewing
    Solicitation
    Similar Opportunities
    6505--Dimethyl Fumarate Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking offers for the procurement of Dimethyl Fumarate Capsules (120MG and 240MG delayed-release) through solicitation 36E79726R0003. This contract aims to establish a reliable supply source for these pharmaceutical products to support VA, Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP) facilities, with a contract structure that includes a one-year base ordering period and four one-year options. The products are critical for treating specific medical conditions, and offerors must comply with stringent requirements, including FDA regulations, Drug Supply Chain Security Act (DSCSA) compliance, and the provision of unique National Drug Codes (NDCs). The deadline for submitting offers has been extended to December 9, 2025, at 2:30 PM CST, and interested parties can contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further information.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Chelmsford & Tucson CMOP - MED/SURG Supplies One Touch-Test Strips, Tandem Infsuion sets 1001680 & 1001729 and Hollister Cath Set #96144
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide specific medical-surgical supplies, including One Touch Verio test strips, Tandem infusion sets (part numbers 1001680 and 1001729), and Hollister Cath Set 96144, for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities located in Chelmsford and Tucson. The procurement is focused on sourcing brand name products only, with strict adherence to quality standards and delivery requirements, including tracking information and compliance with FDA regulations. These supplies are critical for the effective management of patient care within the VA system. Interested vendors must submit their capability statements and relevant company information to Jennifer Knight at jennifer.knight@va.gov by December 9, 2025, at 2:00 PM CT, as this notice serves solely for market research purposes and does not obligate the VA to issue a solicitation.
    MED-SURGE Provox # 8262 - Chelmsford CMOP -
    Buyer not available
    The Department of Veterans Affairs is seeking vendors capable of supplying the Provox 8262 Heat & Moisture Exchanger to the Consolidated Mail Outpatient Pharmacy (CMOP) in Chelmsford, Massachusetts. This Sources Sought Notice aims to gather market research information to identify potential suppliers who can meet specific requirements outlined in the Statement of Requirements, including compliance with delivery terms, barcoding standards, and product authenticity. The Provox 8262 is a critical medical device used in patient care, emphasizing the importance of reliable supply and adherence to regulatory standards. Interested companies must submit their capability statements and relevant documentation to Jennifer L. Knight at jennifer.knight@va.gov by December 11, 2025, at 10:00 AM Central Time, as this notice does not constitute a solicitation for quotes or a contract award.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Buyer not available
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    Q517--Staffing Service Tucson
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for staffing services at its Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, Arizona, under Solicitation Number 36C77022R0008. The contract, which is a firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) agreement, requires the contractor to provide non-personal staffing for various roles, including Pharmacists, Pharmacy Technicians, and Shipper/Packer positions, ensuring a minimum staffing rate of 97% across two shifts. This procurement is critical for maintaining efficient pharmacy operations, processing over 15 million prescriptions annually, and adhering to strict compliance with VA and federal regulations, including HIPAA. Proposals are due by 10:00 AM CST on December 18, 2025, and interested parties should contact Nicholas L. Schulte at nicholas.schulte1@va.gov for further information.
    6505--LANSOPRAZOLE
    Buyer not available
    The Department of Veterans Affairs is seeking to procure Lansoprazole, a pharmaceutical product, for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This procurement is justified as a sole source requirement, indicating that Lansoprazole is essential for the pharmacy's operations and patient care. The drug falls under the category of drugs and biologicals, highlighting its critical role in treating various medical conditions. Interested vendors can reach out to Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov or by phone at 913-946-0150 for further details regarding this opportunity.
    6505--Zonisamide Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the unrestricted procurement of Zonisamide Capsules, which will serve various federal entities including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will be awarded to a single offeror capable of providing an uninterrupted supply of the specified medications, with a contract period of one year and four optional one-year extensions. The procurement is critical for ensuring the availability of these pharmaceutical products, which are essential for patient care within the VA and other federal health facilities. Interested parties should monitor SAM.gov for the solicitation, expected to be issued around December 15, 2025, with a closing date of December 30, 2025, and may direct inquiries to Chris Carthron at Christopher.Carthron@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense (DoD) is soliciting quotes for pharmaceutical agents as part of its Uniform Formulary Blanket Purchase Agreement (UF BPA) and Uniform Formulary Additional Discount Program (UF ADP) through the Defense Health Agency (DHA). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of drugs to determine their classification within the formulary. The P&T Committee will review newly approved drugs, including agents for pulmonary, gynecological, endocrine, atopy, skeletal muscle relaxants, and pain management, with quotes due by December 9, 2025, ahead of the committee meeting scheduled for February 4-5, 2026. Interested manufacturers should contact Stephanie Erpelding or Tracy Banks for further details and ensure compliance with submission requirements outlined in the RFQ HT9402-26-Q-9102.
    VISN 21 Lenalidomide Capsules Multiple Strengths (Generic)
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting a Sources Sought notice to identify vendors capable of supplying Lenalidomide Capsules in multiple strengths, specifically for VISN 21, which includes locations in California, Hawaii, Nevada, and Manila, Philippines. The contractor must be a Certified Lenalidomide REMS Pharmacy, licensed in the applicable states, and comply with all relevant federal, state, and VA regulations, including USP <800> for hazardous drugs. This procurement is critical as Lenalidomide is an oral anti-cancer medication, and the contract will span five one-year ordering periods from March 1, 2026, to February 28, 2031, requiring timely and compliant delivery of FDA-approved products. Interested vendors should submit their capability statements and relevant information to David J. Alvarez at david.alvarez4@va.gov by 10:00 AM Pacific Time on December 10, 2025.